The invention relates to a sterile, ready-to-use, pharmaceutical oil-in water emulsion composition for parenteral administration comprising: 0.015 to 1.2% wt./vol. of progestogen； 0.5-30% wt./vol.oil, wherein the oil comprises at least 85% wt.wt. triglyceride； 0.0425-12.5% wt./vol phospholipid； 61.4-99.4% wt./vol. aqueous medium； wherein the phospholipid is present in an amount of 6.8% - 43% of the oil (wt./wt.), and wherein the progestogen is present in an amount greater than or equal to 2.1wt% of the oil, preferably greater than or equal to 2.2wt% of the oil. The invention further relates to the use of the aforementioned composition in therapeutic or prophylactic treatment, said treatment comprising intravenous administration of the pharmaceutical composition.
